Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection

Introduction The postoperative seizure freedom represents an important secondary outcome measure in glioblastoma surgery. Recently, supra-total glioblastoma resection in terms of anterior temporal lobectomy (ATL) has gained growing attention with regard to superior long-term disease control for temp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuro-oncology 2021-04, Vol.152 (2), p.339-346
Hauptverfasser: Borger, Valeri, Hamed, Motaz, Ilic, Inja, Potthoff, Anna-Laura, Racz, Attila, Schäfer, Niklas, Güresir, Erdem, Surges, Rainer, Herrlinger, Ulrich, Vatter, Hartmut, Schneider, Matthias, Schuss, Patrick
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 346
container_issue 2
container_start_page 339
container_title Journal of neuro-oncology
container_volume 152
creator Borger, Valeri
Hamed, Motaz
Ilic, Inja
Potthoff, Anna-Laura
Racz, Attila
Schäfer, Niklas
Güresir, Erdem
Surges, Rainer
Herrlinger, Ulrich
Vatter, Hartmut
Schneider, Matthias
Schuss, Patrick
description Introduction The postoperative seizure freedom represents an important secondary outcome measure in glioblastoma surgery. Recently, supra-total glioblastoma resection in terms of anterior temporal lobectomy (ATL) has gained growing attention with regard to superior long-term disease control for temporal-located glioblastoma compared to conventional gross-total resections (GTR). However, the impact of ATL on seizure outcome in these patients is unknown. We therefore analyzed ATL and GTR as differing extents of resection in regard of postoperative seizure control in patients with temporal glioblastoma and preoperative symptomatic seizures. Methods Between 2012 and 2018, 33 patients with preoperative seizures underwent GTR or ATL for temporal glioblastoma at the authors’ institution. Seizure outcome was assessed postoperatively and 6 months after tumor resection according to the International League Against Epilepsy (ILAE) classification and stratified into favorable (ILAE class 1) versus unfavorable (ILAE class 2–6). Results Overall, 23 out of 33 patients (70%) with preoperative seizures achieved favorable seizure outcome following resection of temporal located glioblastoma. For the ATL group, postoperative seizure freedom was present in 13 out of 13 patients (100%). In comparison, respective rates for the GTR group were 10 out of 20 patients (50%) (p = 0.002; OR 27; 95% CI 1.4–515.9). Conclusions ATL in terms of a supra-total resection strategy was associated with superior favorable seizure outcome following temporal glioblastoma resection compared to GTR. Regarding above mentioned survival benefit following ATL compared to GTR, ATL as an aggressive supra-total resection regime might constitute the surgical modality of choice for temporal-located glioblastoma.
doi_str_mv 10.1007/s11060-021-03705-x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7997820</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2487427740</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-f6db6f3d08cda0f13301c18a0c8f3e8f3c537949d53b311bf09c8e5308504a203</originalsourceid><addsrcrecordid>eNp9Uc1u1DAQthCILi0vwAFZ4tKLYZyx1wkHpKqCFqkSB1qpN8txnMVVEi92suryCDw1TlMK9MDBsjXfj2fmI-QVh7ccQL1LnMMaGBScASqQ7PYJWXGpkClU-JSsgK8Vk5W4PiAvUroBAKGQPycHiFKKosIV-fnV-R9TdDRMow29o36go-u3IZqObjof6s6kMfSGpiluXNy_p12onc2lPTWJzvVtNGMYMz-6lBEfhvza-H4xzfrkErVh2LlhBmfjGFJij0RH5FlruuRe3t-H5OrTx8vTc3bx5ezz6ckFs0KJkbXrpl632EBpGwMtRwRueWnAli26fKxEVYmqkVgj53ULlS2dRCglCFMAHpIPi-92qnvX2NxVHlZvo-9N3OtgvP4XGfw3vQk7rapKlXcGx_cGMXyfXBp175N1XWcGF6akC1EqUSglZuqbR9SbMMW8gsySIKUqSphZxcKy816iax-a4aDnqPUStc5R67uo9W0Wvf57jAfJ72wzARdCytCQs_vz939sfwEnG7nG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2505572800</pqid></control><display><type>article</type><title>Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Borger, Valeri ; Hamed, Motaz ; Ilic, Inja ; Potthoff, Anna-Laura ; Racz, Attila ; Schäfer, Niklas ; Güresir, Erdem ; Surges, Rainer ; Herrlinger, Ulrich ; Vatter, Hartmut ; Schneider, Matthias ; Schuss, Patrick</creator><creatorcontrib>Borger, Valeri ; Hamed, Motaz ; Ilic, Inja ; Potthoff, Anna-Laura ; Racz, Attila ; Schäfer, Niklas ; Güresir, Erdem ; Surges, Rainer ; Herrlinger, Ulrich ; Vatter, Hartmut ; Schneider, Matthias ; Schuss, Patrick</creatorcontrib><description>Introduction The postoperative seizure freedom represents an important secondary outcome measure in glioblastoma surgery. Recently, supra-total glioblastoma resection in terms of anterior temporal lobectomy (ATL) has gained growing attention with regard to superior long-term disease control for temporal-located glioblastoma compared to conventional gross-total resections (GTR). However, the impact of ATL on seizure outcome in these patients is unknown. We therefore analyzed ATL and GTR as differing extents of resection in regard of postoperative seizure control in patients with temporal glioblastoma and preoperative symptomatic seizures. Methods Between 2012 and 2018, 33 patients with preoperative seizures underwent GTR or ATL for temporal glioblastoma at the authors’ institution. Seizure outcome was assessed postoperatively and 6 months after tumor resection according to the International League Against Epilepsy (ILAE) classification and stratified into favorable (ILAE class 1) versus unfavorable (ILAE class 2–6). Results Overall, 23 out of 33 patients (70%) with preoperative seizures achieved favorable seizure outcome following resection of temporal located glioblastoma. For the ATL group, postoperative seizure freedom was present in 13 out of 13 patients (100%). In comparison, respective rates for the GTR group were 10 out of 20 patients (50%) (p = 0.002; OR 27; 95% CI 1.4–515.9). Conclusions ATL in terms of a supra-total resection strategy was associated with superior favorable seizure outcome following temporal glioblastoma resection compared to GTR. Regarding above mentioned survival benefit following ATL compared to GTR, ATL as an aggressive supra-total resection regime might constitute the surgical modality of choice for temporal-located glioblastoma.</description><identifier>ISSN: 0167-594X</identifier><identifier>EISSN: 1573-7373</identifier><identifier>DOI: 10.1007/s11060-021-03705-x</identifier><identifier>PMID: 33554293</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; Aged ; Anterior Temporal Lobectomy - methods ; Brain cancer ; Brain Neoplasms - complications ; Brain Neoplasms - surgery ; Clinical Study ; Convulsions &amp; seizures ; Disease control ; Epilepsy ; Female ; Glioblastoma ; Glioblastoma - complications ; Glioblastoma - surgery ; Humans ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Neurology ; Oncology ; Seizures ; Seizures - etiology ; Seizures - surgery ; Surgery ; Treatment Outcome</subject><ispartof>Journal of neuro-oncology, 2021-04, Vol.152 (2), p.339-346</ispartof><rights>The Author(s) 2021</rights><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-f6db6f3d08cda0f13301c18a0c8f3e8f3c537949d53b311bf09c8e5308504a203</citedby><cites>FETCH-LOGICAL-c474t-f6db6f3d08cda0f13301c18a0c8f3e8f3c537949d53b311bf09c8e5308504a203</cites><orcidid>0000-0002-5905-4121</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11060-021-03705-x$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11060-021-03705-x$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33554293$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Borger, Valeri</creatorcontrib><creatorcontrib>Hamed, Motaz</creatorcontrib><creatorcontrib>Ilic, Inja</creatorcontrib><creatorcontrib>Potthoff, Anna-Laura</creatorcontrib><creatorcontrib>Racz, Attila</creatorcontrib><creatorcontrib>Schäfer, Niklas</creatorcontrib><creatorcontrib>Güresir, Erdem</creatorcontrib><creatorcontrib>Surges, Rainer</creatorcontrib><creatorcontrib>Herrlinger, Ulrich</creatorcontrib><creatorcontrib>Vatter, Hartmut</creatorcontrib><creatorcontrib>Schneider, Matthias</creatorcontrib><creatorcontrib>Schuss, Patrick</creatorcontrib><title>Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection</title><title>Journal of neuro-oncology</title><addtitle>J Neurooncol</addtitle><addtitle>J Neurooncol</addtitle><description>Introduction The postoperative seizure freedom represents an important secondary outcome measure in glioblastoma surgery. Recently, supra-total glioblastoma resection in terms of anterior temporal lobectomy (ATL) has gained growing attention with regard to superior long-term disease control for temporal-located glioblastoma compared to conventional gross-total resections (GTR). However, the impact of ATL on seizure outcome in these patients is unknown. We therefore analyzed ATL and GTR as differing extents of resection in regard of postoperative seizure control in patients with temporal glioblastoma and preoperative symptomatic seizures. Methods Between 2012 and 2018, 33 patients with preoperative seizures underwent GTR or ATL for temporal glioblastoma at the authors’ institution. Seizure outcome was assessed postoperatively and 6 months after tumor resection according to the International League Against Epilepsy (ILAE) classification and stratified into favorable (ILAE class 1) versus unfavorable (ILAE class 2–6). Results Overall, 23 out of 33 patients (70%) with preoperative seizures achieved favorable seizure outcome following resection of temporal located glioblastoma. For the ATL group, postoperative seizure freedom was present in 13 out of 13 patients (100%). In comparison, respective rates for the GTR group were 10 out of 20 patients (50%) (p = 0.002; OR 27; 95% CI 1.4–515.9). Conclusions ATL in terms of a supra-total resection strategy was associated with superior favorable seizure outcome following temporal glioblastoma resection compared to GTR. Regarding above mentioned survival benefit following ATL compared to GTR, ATL as an aggressive supra-total resection regime might constitute the surgical modality of choice for temporal-located glioblastoma.</description><subject>Adult</subject><subject>Aged</subject><subject>Anterior Temporal Lobectomy - methods</subject><subject>Brain cancer</subject><subject>Brain Neoplasms - complications</subject><subject>Brain Neoplasms - surgery</subject><subject>Clinical Study</subject><subject>Convulsions &amp; seizures</subject><subject>Disease control</subject><subject>Epilepsy</subject><subject>Female</subject><subject>Glioblastoma</subject><subject>Glioblastoma - complications</subject><subject>Glioblastoma - surgery</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Oncology</subject><subject>Seizures</subject><subject>Seizures - etiology</subject><subject>Seizures - surgery</subject><subject>Surgery</subject><subject>Treatment Outcome</subject><issn>0167-594X</issn><issn>1573-7373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9Uc1u1DAQthCILi0vwAFZ4tKLYZyx1wkHpKqCFqkSB1qpN8txnMVVEi92suryCDw1TlMK9MDBsjXfj2fmI-QVh7ccQL1LnMMaGBScASqQ7PYJWXGpkClU-JSsgK8Vk5W4PiAvUroBAKGQPycHiFKKosIV-fnV-R9TdDRMow29o36go-u3IZqObjof6s6kMfSGpiluXNy_p12onc2lPTWJzvVtNGMYMz-6lBEfhvza-H4xzfrkErVh2LlhBmfjGFJij0RH5FlruuRe3t-H5OrTx8vTc3bx5ezz6ckFs0KJkbXrpl632EBpGwMtRwRueWnAli26fKxEVYmqkVgj53ULlS2dRCglCFMAHpIPi-92qnvX2NxVHlZvo-9N3OtgvP4XGfw3vQk7rapKlXcGx_cGMXyfXBp175N1XWcGF6akC1EqUSglZuqbR9SbMMW8gsySIKUqSphZxcKy816iax-a4aDnqPUStc5R67uo9W0Wvf57jAfJ72wzARdCytCQs_vz939sfwEnG7nG</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Borger, Valeri</creator><creator>Hamed, Motaz</creator><creator>Ilic, Inja</creator><creator>Potthoff, Anna-Laura</creator><creator>Racz, Attila</creator><creator>Schäfer, Niklas</creator><creator>Güresir, Erdem</creator><creator>Surges, Rainer</creator><creator>Herrlinger, Ulrich</creator><creator>Vatter, Hartmut</creator><creator>Schneider, Matthias</creator><creator>Schuss, Patrick</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5905-4121</orcidid></search><sort><creationdate>20210401</creationdate><title>Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection</title><author>Borger, Valeri ; Hamed, Motaz ; Ilic, Inja ; Potthoff, Anna-Laura ; Racz, Attila ; Schäfer, Niklas ; Güresir, Erdem ; Surges, Rainer ; Herrlinger, Ulrich ; Vatter, Hartmut ; Schneider, Matthias ; Schuss, Patrick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-f6db6f3d08cda0f13301c18a0c8f3e8f3c537949d53b311bf09c8e5308504a203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anterior Temporal Lobectomy - methods</topic><topic>Brain cancer</topic><topic>Brain Neoplasms - complications</topic><topic>Brain Neoplasms - surgery</topic><topic>Clinical Study</topic><topic>Convulsions &amp; seizures</topic><topic>Disease control</topic><topic>Epilepsy</topic><topic>Female</topic><topic>Glioblastoma</topic><topic>Glioblastoma - complications</topic><topic>Glioblastoma - surgery</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Oncology</topic><topic>Seizures</topic><topic>Seizures - etiology</topic><topic>Seizures - surgery</topic><topic>Surgery</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Borger, Valeri</creatorcontrib><creatorcontrib>Hamed, Motaz</creatorcontrib><creatorcontrib>Ilic, Inja</creatorcontrib><creatorcontrib>Potthoff, Anna-Laura</creatorcontrib><creatorcontrib>Racz, Attila</creatorcontrib><creatorcontrib>Schäfer, Niklas</creatorcontrib><creatorcontrib>Güresir, Erdem</creatorcontrib><creatorcontrib>Surges, Rainer</creatorcontrib><creatorcontrib>Herrlinger, Ulrich</creatorcontrib><creatorcontrib>Vatter, Hartmut</creatorcontrib><creatorcontrib>Schneider, Matthias</creatorcontrib><creatorcontrib>Schuss, Patrick</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of neuro-oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Borger, Valeri</au><au>Hamed, Motaz</au><au>Ilic, Inja</au><au>Potthoff, Anna-Laura</au><au>Racz, Attila</au><au>Schäfer, Niklas</au><au>Güresir, Erdem</au><au>Surges, Rainer</au><au>Herrlinger, Ulrich</au><au>Vatter, Hartmut</au><au>Schneider, Matthias</au><au>Schuss, Patrick</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection</atitle><jtitle>Journal of neuro-oncology</jtitle><stitle>J Neurooncol</stitle><addtitle>J Neurooncol</addtitle><date>2021-04-01</date><risdate>2021</risdate><volume>152</volume><issue>2</issue><spage>339</spage><epage>346</epage><pages>339-346</pages><issn>0167-594X</issn><eissn>1573-7373</eissn><abstract>Introduction The postoperative seizure freedom represents an important secondary outcome measure in glioblastoma surgery. Recently, supra-total glioblastoma resection in terms of anterior temporal lobectomy (ATL) has gained growing attention with regard to superior long-term disease control for temporal-located glioblastoma compared to conventional gross-total resections (GTR). However, the impact of ATL on seizure outcome in these patients is unknown. We therefore analyzed ATL and GTR as differing extents of resection in regard of postoperative seizure control in patients with temporal glioblastoma and preoperative symptomatic seizures. Methods Between 2012 and 2018, 33 patients with preoperative seizures underwent GTR or ATL for temporal glioblastoma at the authors’ institution. Seizure outcome was assessed postoperatively and 6 months after tumor resection according to the International League Against Epilepsy (ILAE) classification and stratified into favorable (ILAE class 1) versus unfavorable (ILAE class 2–6). Results Overall, 23 out of 33 patients (70%) with preoperative seizures achieved favorable seizure outcome following resection of temporal located glioblastoma. For the ATL group, postoperative seizure freedom was present in 13 out of 13 patients (100%). In comparison, respective rates for the GTR group were 10 out of 20 patients (50%) (p = 0.002; OR 27; 95% CI 1.4–515.9). Conclusions ATL in terms of a supra-total resection strategy was associated with superior favorable seizure outcome following temporal glioblastoma resection compared to GTR. Regarding above mentioned survival benefit following ATL compared to GTR, ATL as an aggressive supra-total resection regime might constitute the surgical modality of choice for temporal-located glioblastoma.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>33554293</pmid><doi>10.1007/s11060-021-03705-x</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-5905-4121</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0167-594X
ispartof Journal of neuro-oncology, 2021-04, Vol.152 (2), p.339-346
issn 0167-594X
1573-7373
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7997820
source MEDLINE; SpringerNature Journals
subjects Adult
Aged
Anterior Temporal Lobectomy - methods
Brain cancer
Brain Neoplasms - complications
Brain Neoplasms - surgery
Clinical Study
Convulsions & seizures
Disease control
Epilepsy
Female
Glioblastoma
Glioblastoma - complications
Glioblastoma - surgery
Humans
Male
Medicine
Medicine & Public Health
Middle Aged
Neurology
Oncology
Seizures
Seizures - etiology
Seizures - surgery
Surgery
Treatment Outcome
title Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T18%3A40%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Seizure%20outcome%20in%20temporal%20glioblastoma%20surgery:%20lobectomy%20as%20a%20supratotal%20resection%20regime%20outclasses%20conventional%20gross-total%20resection&rft.jtitle=Journal%20of%20neuro-oncology&rft.au=Borger,%20Valeri&rft.date=2021-04-01&rft.volume=152&rft.issue=2&rft.spage=339&rft.epage=346&rft.pages=339-346&rft.issn=0167-594X&rft.eissn=1573-7373&rft_id=info:doi/10.1007/s11060-021-03705-x&rft_dat=%3Cproquest_pubme%3E2487427740%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2505572800&rft_id=info:pmid/33554293&rfr_iscdi=true